We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Galson: Keep ODS, OND Under CDER's Organizational Structure
Galson: Keep ODS, OND Under CDER's Organizational Structure
May 13, 2005
Having the FDA’s new drugs office and drug safety office within the agency’s Center for Drug Evaluation and Research (CDER) ensures efficient decisionmaking, expeditious resolution of disputes and the rapid dissemination of critical drug safety information, said the head of CDER.